PODD

MKT CAP:$10B

Insulet Corporation

Market Cap

$10B

Healthcare·Medical Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical Devices·🇺🇸·NASDAQ

Stock Price

$151.51-$131.41 (-46.45%)

Jun 8, 2026

52W High $352.8252W Low $142.43

Company Details

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated ...

CEO

—

IPO Date

May 15, 2007

Website

www.insulet.com

Key Metrics TTM

Revenue

$2.9B

+31.9% YoY

Net Income

$303M

EPS (Diluted)

Free Cash Flow

$412M

Revenue / Share

$41.32

Gross Margin

71.0%

Operating Margin

17.5%

Net Margin

10.4%

FCF Margin

14.2%

P/S

3.5x

P/E

33.9x

Earnings Reports

Q2 2026

Aug 6, 2026

PENDING

Q1 2026

May 6, 2026

$762M+33.9%

FY 2025

Feb 18, 2026

$2.7B+30.7%

Q4 2025

Feb 18, 2026

$784M+31.2%

Q3 2025

Nov 6, 2025

$706M+29.9%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee